MARKET

CRBU

CRBU

Caribou Biosciences, Inc.
NASDAQ
1.630
+0.010
+0.62%
After Hours: 1.640 +0.01 +0.61% 17:55 12/18 EST
OPEN
1.630
PREV CLOSE
1.620
HIGH
1.745
LOW
1.620
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
3.535
52 WEEK LOW
0.6600
MARKET CAP
152.35M
P/E (TTM)
-0.9602
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRBU last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at CRBU last week (1201-1205)?
Weekly Report · 12/08 10:04
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU)
TipRanks · 12/07 23:55
Caribou Biosciences Hosts KOL Panel on Allogeneic CAR-T Access at ASH Annual Meeting
Reuters · 12/01 21:05
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
Barchart · 12/01 15:05
Weekly Report: what happened at CRBU last week (1124-1128)?
Weekly Report · 12/01 10:00
Weekly Report: what happened at CRBU last week (1117-1121)?
Weekly Report · 11/24 10:04
FORMER AMAZON AND PEPSICO LEADER CHRIS WINKLER JOINS CARIBOU AS SVP, REVENUE & OPERATIONS
Reuters · 11/18 13:52
More
About CRBU
Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company engaged in developing transformative therapies for patients with devastating diseases. The Company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T platform to offer broad access and rapid availability of treatments for patients with hematologic malignancies and autoimmune diseases. Its genome-editing platform, including its novel chRDNA technology, enables more precise genome editing of allogeneic cell therapies. It is advancing its pipeline of allogeneic CAR-T cell therapies with clinical development programs targeting the treatment of hematologic malignancies and autoimmune diseases.

Webull offers Caribou Biosciences Inc stock information, including NASDAQ: CRBU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRBU stock methods without spending real money on the virtual paper trading platform.